Barr Will Begin First Self-Sponsored Clinical Trial For An NDA This Fall

Barr Labs will begin clinical trials on a prostate cancer therapy this fall, the first time it will be conducting its own clinical trials, Barr CEO Bruce Downey said during an Aug. 10 teleconference.